Patents by Inventor Marina Pliushchev

Marina Pliushchev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
    Publication number: 20050245532
    Abstract: The present invention relates to the use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment or prophylactically treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, and other diseases and conditions mediated by excessive glucocorticoid action.
    Type: Application
    Filed: April 29, 2004
    Publication date: November 3, 2005
    Inventors: Ethan Hoff, James Link, Marina Pliushchev, Jeffrey Rohde, Martin Winn
  • Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
    Publication number: 20050245534
    Abstract: The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, and other diseases and conditions that are mediated by excessive glucocorticoid action.
    Type: Application
    Filed: October 14, 2004
    Publication date: November 3, 2005
    Inventors: James Link, Marina Pliushchev, Jeffrey Rohde, Dariusz Wodka, Jyoti Patel, Qi Shuai
  • Inhibitors of the 11-beta-hydroxysteroid dehydrogenaseType 1 enzyme and their therapeutic application
    Publication number: 20050245533
    Abstract: The present invention relates to the use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment or prophylactically treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, and other diseases and conditions mediated by excessive glucocorticoid action.
    Type: Application
    Filed: October 14, 2004
    Publication date: November 3, 2005
    Inventors: Ethan Hoff, James Link, Marina Pliushchev, Jeffrey Rohde, Martin Winn
  • Oxazolidinone chemotherapeutic agents
    Patent number: 6410728
    Abstract: Compounds of the formula or therapeutically acceptable salts or prodrugs thereof, are useful for treating bacterial infections, psoriasis, arthritis, and toxicity due to chemotherapy. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.
    Type: Grant
    Filed: June 19, 2001
    Date of Patent: June 25, 2002
    Assignee: Abbott Laboratories
    Inventors: Richard J. Sciotti, Stevan W. Djuric, Marina Pliushchev
  • OXAZOLIDINONE CHEMOTHERAPEUTIC AGENTS
    Publication number: 20020045625
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: June 19, 2001
    Publication date: April 18, 2002
    Inventors: Richard J. Sciotti, Stevan W. Djuric, Marina Pliushchev
  • Oxazolidinone chemotherapeutic agents
    Patent number: 6277868
    Abstract: Compounds of formula (I) or therapeutically acceptable salts or prodrugs thereof, are useful for treating bacterial infections, psoriasis, arthritis, and toxicity due to chemotherapy. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: August 21, 2001
    Assignee: Abbott Laboratories
    Inventors: Richard J. Sciotti, Stevan W. Djuric, Marina Pliushchev